Emergency Medicine Doctors in Galveston, TX Accepting Medicare

27 Emergency Medicine doctors found. Showing 21 - 27

Stephen Kim, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-6576

Dr. Mark Nikbakht, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: University Of Texas Medical Br, 301 University Blvd, Galveston, TX 77555 Phone: 409-772-7118    Fax: 409-772-9068

Marie Sophia Samuels, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-7118    Fax: 409-772-9068

Dr. Stephen Oliver Morrical, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Harborside Dr, Galveston, TX 77550 Phone: 409-772-1161

Moustafa El Sayed, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-1011

Dr. Gursaran Banipal Morrical, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 901 Harborside Dr, Galveston, TX 77550 Phone: 409-772-1191

Iftikhar Ali, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-0817    Fax: 409-772-0885

News Archive

Lumosity develops big data methodology for conducting human cognitive performance research

Lumosity, the leading brain training company, today announced a new web-based, big data methodology for conducting human cognitive performance research. Lumosity's research platform, the Human Cognition Project, contains the world's largest and continuously growing dataset of human cognitive performance, which currently includes more than 40 million people who have been tracked for up to 6 years.

Study elucidates pathophysiology of systemic lupus erythematosus

Osaka University researchers elucidated the pathophysiology of systemic lupus erythematosus, an autoimmune disorder that causes inflammation and tissue damage.

Blocking estrogen may be vitally important to improving survival from lung cancer

New and effective treatments for lung cancer may rest on their ability to hinder the action of estrogen in lung cancer cells, according to two studies published in the current issue of Cancer Research.

Study packs powerful one-two punch in the fight against heart failure

A new study in the journal Circulation packs a powerful one-two punch in the fight against heart failure. The leading blow: Identification of a unique alliance of proteins that plays a major role in the development of the disease. The second but equally powerful hit: Drugs that interfere with this axis already exist.

Read more Medical News

› Verified 7 days ago

• 1
• 2(current)